Latest advances and outcomes from the treatment of acute leukemia today
Leukemia is a blood cancer that can be identified by the rapid growth of defective
blood cells. The marrow of our bone produces most of the blood in our body which is
the site of this abnormal growth. Typically, leukemia cells are immature white blood
cells. Leukemic cells alter the normal blood cell formation process, leading to various
signs and symptoms such as bleeding, infection, and tiredness.
There are two kinds of leukemia: acute leukemia and chronic leukemia. Further, the
acute type was classified into acute myeloid leukaemia (AML) and acute
lymphoblastic leukaemia (ALL). Myeloblasts, or defective white blood cells, are the
cause of acute myeloid leukaemia (AML). Acute myelogenous, granulocytic,
nonlymphocytic, or myeloblastic leukaemia are other terms for this kind of cancer.
However, the overproduction of lymphocytes is caused by acute lymphoblastic
leukaemia (ALL).
Stem cell transplantation, radiation therapy, and chemotherapy have been the
cornerstones of leukaemia treatment. Targeted therapy has also been included in the
standard of care for certain kinds of leukaemia within the past 20 years. These
medications target the proteins that regulate the growth, division, and metastasis of
cancer cells. Different treatment combinations are needed for different forms of
leukaemia.
For Acute lymphocytic leukemia (ALL), Immunotherapies are being used where
many elderly people are unable to handle the severe side effects of the intense
chemotherapy therapies required to treat ALL. Compared to chemotherapy, targeted
therapies might have fewer adverse effects.
Immunotherapies are treatments that enhance the body's ability to fight cancer
through the immune system. Currently, four immunotherapies are FDA approved for
the treatment of ALL: blinatumomab, inotuzumab ozogamicin, tisagenlecleucel and
midostaurin. In ALL, the following immunotherapy techniques are being tested or
employed are CAR T-cell therapy and bispecific T-cell engagers (BiTEs). A sort of
cancer treatment called CAR T-cell therapy involves genetically modifying the
patient & own immune cells. For the treatment of some children and young adults with
ALL, one kind of CAR T cell therapy is currently approved. Dosing is based on
weight reported at the time of leukapheresis.The use of this type in elderly B-cell
ALL patients is now being investigated. Adults with B-cell precursor ALL who have
not responded to previous treatment or have returned after treatment have been
approved for another course of CAR T-cell therapy.
Bispecific T-cell engagers (BiTEs) are another immunotherapy that is being studied
for ALL. These medications bind to both cancer and immune cells, drawing the two
groups of cells closer together so that the immune cells can locate and eliminate the
cancer cells with ease. Recently, it was demonstrated that one such BiTE,
blinatumomab, can increase survival for ALL patients in remission following
chemotherapy, even in situations where the disease is completely eradicated.
Acute myeloid leukaemia (AML) tends to be aggressive and was harder to treat than
ALL. However, AML cells sometimes have gene changes that cause the tumors to
grow but can be targeted with new drugs. The management of AML involves two
phases such as remission induction therapy (first phase of treatment to kill
the leukemia cells in the blood and bone marrow ) and remission continuation therapy
(second phase of treatment to kill any remaining leukemia cells).
The treatment of AML includes chemotherapy (drugs to stop the growth of cancer
cells), radiation therapy (uses high-energy x-rays or other types of radiation to kill
cancer cells), stem cell transplant (to replace the blood-forming cells from the blood
or bone marrow of the patient) and targeted therapy (drugs or other substances to
identify and attack specific cancer cells) or combination of both. Targeted treatments
such as Enasidenib, Olutasidenib, Ivosidenib, Venetoclax, Gemtuzumab ozogamicin,
Midostaurin, Gilteritinib, Glasdegib, and Quizartinib have recently been approved to
treat AML with specific gene alterations.
In order to achieve complete remission (CR) from acute leukaemia, standard
treatment paradigms have involved high-intensity induction chemotherapy. In certain
cases, this was followed by an allogeneic hematopoietic cell transplant (allo-HCT) to
eliminate residual disease through the "graft versus leukaemia effect, which is
mediated by the immune cells of the donor. Allo-HCT is not recommended for all
patients, though, and one of the biggest problems facing the industry at the moment is
the lack of viable chemotherapy-based choices for patients who relapse after allo-
HCT or who develop chemotherapy-refractory illness.
The potential of immunotherapy in the treatment of acute myeloid leukaemia (AML)
has been established by the effectiveness of allogeneic stem cell transplantation.
Alternative T-cell-based immunotherapies have demonstrated effectiveness, but there
is a chance that they could cause on-target off-leukemia hematotoxicity. Currently,
the use of adoptive autologous or allogeneic chimeric antigen receptor (CAR) T /
natural killer cell treatment as a bridge-to-transplant approach is almost only available
in clinical studies.
Acute leukaemia used to be nearly always fatal, but now it has a 63% 5-year survival
rate in the US. The therapeutic options for acute leukaemia have increased with the
introduction of immunotherapy, however, the advancement in AML has been slower.
Novel medicines such as ADCs, CAR T cell treatments, and BiTEs continue to show
remarkable response rates and favourable toxicity profiles in various disease states
every year. Even with these developments, a large number of patients are still not
eligible for immunotherapeutic treatments, and relapses following some of the more
recent modalities are still linked to extremely poor prognoses. In the future, new
medicines with potentially unique mechanisms of action will probably be approved
together with the expansion of the indications for currently available medications.
References:
1. Leukemia. National Cancer Institute. Available at:
https://www.cancer.gov/types/leukemia/hp/adult-aml-treatment-pdq
2. Boyiadzis MM, Aksentijevich I, Arber DA, et al. The Society for Immunotherapy
of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of
acute leukemia. Journal for ImmunoTherapy of Cancer. 2020
3. Kantarjian, H., Kadia, T., DiNardo, C. et al. Acute myeloid leukemia: current
progress and future directions. Blood Cancer J. 2021
4. Subklewe M, Bücklein V, Sallman D, Daver N. Novel immunotherapies in the
treatment of AML: is there hope? Hematology Am Soc Hematol Educ Program. 2023
Dec 8;2023
Share:
More Posts

Advanced Treatment for Cervical Cancer Bangalore
Advanced Treatment for Cervical Cancer Bangalore Book an Appointment Cervical Cancer: Preventable Today, Curable When Detected Early Cervical cancer begins in the cervix, the lower part of the uterus, and usually develops slowly over many years. Early abnormal cell changes often occur before cancer develops and can be detected through screening. Because early cervical cancer may not cause symptoms, prevention and early detection are the most powerful tools to reduce illness and death. At Healius Cancer Clinic, we are committed to changing the narrative around women’s health by providing the most advanced treatment for cervical cancer in Bangalore alongside world-class screening and treatment protocols. The Primary Cause: HPV The primary cause of cervical cancer is persistent infection with Human Papillomavirus (HPV). HPV is extremely common, and most infections clear naturally. However, certain high-risk HPV types can remain in the body and cause progressive damage to cervical cells, eventually leading to cancer if not detected early. The Burden in India India carries a significant share of the global cervical cancer burden, with approximately 1.2–1.3 lakh new cases and 75,000–80,000 deaths every year. Nearly 60–65% of affected women die, largely due to late diagnosis. These numbers underline the critical importance of vaccination, screening, and timely treatment at specialized centers like Healius Cancer Clinic. Prevention Through Vaccination – A Key Pillar Preventive (Prophylactic) HPV Vaccines HPV vaccines protect against the types most commonly responsible for cervical cancer. These are preventive, meaning they work best before exposure to HPV and do not treat existing infections. Healius Cancer Clinic provides access to leading vaccine brands: Gardasil® / Gardasil 9®: Protects against multiple high-risk HPV types and types causing genital warts. Cervarix®: Targets the two most important high-risk HPV types associated with cervical cancer. Recommendation: Vaccination is ideal between 9 and 14 years of age, before the onset of sexual activity, but can also be given later based on medical advice. Screening and Early Detection Even vaccinated individuals need screening. Regular Pap smears and HPV testing can detect abnormal cells before they become cancerous. Regular screening at our Bangalore clinic significantly lowers cervical cancer incidence and mortality. Advanced Cervical Cancer Treatment in Bangalore At Healius Cancer Clinic, treatment is planned by a multidisciplinary oncology team based on the stage, tumor size, and the patient’s fertility wishes. Surgical Treatment Surgery is the main treatment for early-stage disease. Options include: Conization or Simple Hysterectomy: For very early cases. Radical Hysterectomy: Removal of surrounding tissues and lymph nodes for slightly more advanced early stages. Radical Trachelectomy: A fertility-sparing surgery for young women who wish to preserve their ability to conceive. Radiation Therapy Radiation plays a major role, especially in locally advanced disease. We utilize: External Beam Radiation Therapy (EBRT) Brachytherapy: Internal radiation placed close to the cervix. Modern techniques at Healius allow for precise targeting, protecting organs like the bladder and bowel. Chemotherapy and Targeted Therapy Concurrent Chemoradiation: Giving chemotherapy with radiation is the standard for locally advanced stages. Targeted Therapy: Uses drugs that inhibit tumor blood vessel formation (angiogenesis), starving the tumor of its blood supply. Immunotherapy: Helping the body’s immune system recognize and destroy cancer cells, especially in advanced or recurrent cases. Genetic and Molecular Insights Cervical cancer is primarily driven by HPV-related genetic damage rather than inherited mutations. Unlike breast or ovarian cancer, it is rarely hereditary. HPV infection remains the dominant risk factor, making it a disease that is largely preventable through lifestyle and medical intervention. Building Awareness for a Healthier Future Awareness among school children and the general public is essential. By understanding that cervical cancer is preventable, we remove the fear and stigma around women’s health. As emphasized by the World Health Organization, cervical cancer can be eliminated through widespread vaccination and screening. Healius Cancer Clinic stands as a partner for women in Bangalore, protecting future generations through education and early medical care. Take Charge of Your Health Today Don’t wait for symptoms to appear. Whether you need an HPV vaccination for your child or a screening for yourself, our experts are here to help. Healius Cancer Clinic – Bangalore Contact Us: +91 9900613143 Website Link: https://healiuscancerhematology.com/

Childhood Glioma treatment options in bangalore
Childhood glioma Treatment Options In Bangalore Book an Appointment Childhood Glioma: Understanding the Disease, Empowering Hope at Healius Cancer Clinic Childhood gliomas are the most common brain tumors in children. They arise from glial cells, which support nerve cells in the brain and spinal cord. Many pediatric gliomas are slow-growing and treatable. At Healius Cancer Clinic, we provide a comprehensive range of Child Hood Glioma Treatment Options In Bangalore, utilizing the latest advances in molecular testing and targeted therapies to significantly improve outcomes and the quality of life for our young patients. What is Childhood Glioma? These tumors are a group of diverse diseases rather than a single condition. While a diagnosis is overwhelming, it is important to know that many cases are highly manageable with the right expertise. Types of Childhood Glioma Low-Grade Gliomas (LGG) These are slow-growing tumors such as pilocytic astrocytoma, diffuse low-grade astrocytoma, and ganglioglioma. Many children do very well, especially when surgical removal at Healius Cancer Clinic is possible. High-Grade Gliomas (HGG) These are faster-growing and more aggressive tumors, including diffuse pediatric-type high-grade glioma and diffuse midline glioma. These require intensive, multidisciplinary management. Advanced Diagnosis: Molecular and Genetic Classification Modern diagnosis at Healius combines traditional histology with cutting-edge molecular markers. Understanding the genetic “driver” of the tumor is essential for treatment planning. Key groups include: MAPK pathway–altered gliomas BRAF-altered and H3-altered gliomas NF1-associated gliomas Gene Fusions in Childhood Glioma Gene fusions (like KIAA1549–BRAF) play a major role in pediatric low-grade gliomas. Fusion-positive tumors often have favorable outcomes and respond exceptionally well to the targeted therapies we provide in Bangalore. Personalized Treatment Options in Healius Surgery Surgery is the first and most important treatment when safely possible. At Healius Cancer Clinic, our surgical goal is complete removal, which can be curative for many low-grade gliomas. Chemotherapy Used when surgery is incomplete or unsafe, chemotherapy helps control tumor growth and delay radiotherapy. We use carefully dosed regimens like Carboplatin + Vincristine or Vinblastine to minimize long-term side effects. Radiotherapy Radiation is used cautiously, mainly for aggressive tumors. We employ modern techniques such as IMRT to precisely target the tumor. Because a child’s brain is still developing, our specialists at Healius often delay or avoid radiation in very young children whenever possible. Targeted Therapy These medicines act on specific genetic changes and are often better tolerated than traditional chemo. BRAF & MEK Inhibitors: Block abnormal signaling to shrink tumors. FGFR & mTOR Inhibitors: Used for specific genetic alterations. Immunotherapy and Clinical Trials While still evolving, Healius Cancer Clinic stays at the forefront of research. Immunotherapy helps the body’s immune system attack tumor cells through: Immune checkpoint inhibitors CAR-T cell therapy (Experimental) Oncolytic viral therapy Causes, Prognosis, and Long-Term Care In most children, no clear cause is identified. Childhood gliomas are not caused by diet, mobile phones, or parenting choices. Prognosis: While high-grade gliomas remain challenging, low-grade gliomas often allow children to live long, fulfilling lives. At Healius, our long-term care focuses on the “whole child”—including learning support, hormonal health, and emotional well-being. Key Take-Home Message from Healius Cancer Clinic Childhood glioma treatment must be personalized. By combining molecular testing with compassionate care, we aim to control the tumor while protecting your child’s future. 📍 Visit Healius Cancer Clinic in Bangalore for expert pediatric neuro-oncology consultations. Contact Us: +91 9900613143

Best Supportive Care for Cancer Patients Bangalore
Best Supportive Care for Cancer Patients Bangalore Book an Appointment Beyond the Cure: How Palliative Care Transforms Quality of Life for Lung Cancer Patients Looking Beyond Treatment Alone A lung cancer diagnosis brings a wave of fear, uncertainty, and physical discomfort. While treatments like chemotherapy, radiation, and surgery are central, receiving the best supportive care for cancer patients in Bangalore is equally vital. At Healius Cancer Clinic, we believe in a holistic approach through palliative care. This supportive strategy enhances the quality of life from the very beginning of the journey, ensuring our patients feel comfortable, informed, and deeply supported at every stage of their treatment. Providing the Best Supportive Care for Cancer Patients in Bangalore: What Exactly Is Palliative Care? Palliative care is specialised medical support focused on easing symptoms, reducing stress, and improving daily comfort. It is not limited to the final stages of illness. Instead, it works alongside cancer treatment, helping patients cope physically and emotionally. For lung cancer patients—who often face breathlessness, cough, pain, fatigue, and anxiety—this support becomes invaluable. Why Palliative Care Matters in Lung Cancer Lung cancer symptoms can significantly affect quality of life. Breathlessness can be frightening, fatigue can limit daily activity, and chronic cough or chest discomfort can cause frustration and stress. Palliative care helps manage these challenges early and effectively, allowing patients to stay more active, sleep better, and feel more in control. As symptoms improve, many patients also tolerate chemotherapy or radiation more comfortably and with fewer interruptions. Holistic Symptom Relief Palliative care provides targeted and holistic symptom relief. Breathlessness can be managed through breathing exercises, positioning techniques, nebulisation, and medications that calm both the lungs and the mind. Pain, fatigue, and cough are treated with a personalised combination of medicines, physiotherapy, and non-medical relaxation techniques. When symptoms are under control, patients often experience renewed energy and confidence. Emotional and Psychological Support Cancer affects not just the body but also the mind. Feelings of fear, sadness, stress, or uncertainty are all normal—but they can become overwhelming without support. Palliative care teams include counsellors, psychologists, and trained nurses who help patients and families navigate these emotions. Regular counselling, coping strategies, and reassurance can reduce emotional distress. Caregivers also receive support, helping them manage responsibilities with compassion and strength. Nutrition, Strength, and Energy Many lung cancer patients struggle with appetite loss, altered taste, weight loss, and low energy. These issues can affect treatment tolerance and wellbeing. Palliative care teams work with nutritionists to build simple, personalised meal plans that boost strength, immunity, and digestion. Even small improvements in appetite or energy can meaningfully improve quality of life. Better Communication and Care Planning The journey through lung cancer involves many decisions, and families often feel overwhelmed. Palliative care provides clear, compassionate communication that helps patients understand their condition, anticipate changes, and make informed choices. These conversations empower families and ensure care aligns with patient values and comfort. Why Early Palliative Care Makes a Difference Early palliative care—started from diagnosis—has been shown to improve mood, reduce symptom burden, enhance quality of life, and even extend survival. It is a parallel form of support that enhances medical treatment rather than replacing it. Everyday Impact: What Palliative Care Looks Like In daily life, palliative care may look like guidance during breathlessness, a diet plan that regains appetite, or a counselling session that reduces anxiety. It may also include physiotherapy for mobility or nursing support for home care. These small actions collectively bring comfort, confidence, and dignity to the cancer journey. A Compassionate Choice Choosing palliative care is not giving up; it is choosing to live better. At Healius Cancer Clinic, we ensure this journey brings comfort, clarity, and emotional strength during a challenging time. For lung cancer patients and families in Bangalore, our care goes beyond curing disease—it is about nurturing the mind, body, and spirit, helping patients live not just longer, but better. For Palliative Care (Supportive care focus) “Don’t navigate this journey alone. Experience the best supportive care for cancer patients in Bangalore at Healius Cancer Clinic. Let us help you improve your quality of life. 📞 Call us to learn how we can support you. Contact Number: +91 9900613143 Contact Us: https://healiuscancerhematology.com/contact/

Understanding Rhabdomyosarcoma (RMS): A Comprehensive Guide for Parents and Caregivers
Understanding Rhabdomyosarcoma (RMS): A Comprehensive Guide for Parents and Caregivers What is Rhabdomyosarcoma? As a malignant soft tissue sarcoma, Rhabdomyosarcoma stems from primitive mesenchymal cells that fail to mature into skeletal muscle, leading to tumor formation. Managing such a condition requires specialized attention. Healius Clinic is dedicated to offering the best supportive care for cancer patients in Bangalore, focusing on advanced symptom management and comprehensive patient support during RMS treatment. Rhabdomyosarcoma is a malignant soft tissue sarcoma originating from primitive mesenchymal cells—the early cells that should ideally mature into skeletal muscle. Instead, these cells undergo uncontrolled growth, forming tumors. While it mimics muscle tissue, RMS can appear in various parts of the body, including: Head & Neck: Eye orbits, sinuses, or throat. Genitourinary Tract: Bladder, prostate, or paratesticular areas. Extremities: Arms and legs. Trunk: Abdomen or pelvis. Why is RMS Unique? RMS is distinct due to its predictable yet aggressive nature: Age-Specific: Most common in children under 10, though certain types affect adolescents. Subtypes Matter: Embryonal RMS: Most common, often seen in younger children with generally better outcomes. Alveolar RMS: More aggressive, typically seen in older children/teens. Molecular Signatures: Specific genetic “fusions” help our experts at Healius predict tumor behavior and customize the intensity of the treatment. Causes and Prevention The Facts for Parents: No Fault: RMS is caused by random genetic mutations during early development. It is not caused by diet, lifestyle, or anything a parent did or didn’t do. Prevention: Currently, there is no known way to prevent RMS. However, early detection is the most powerful tool for a successful cure. Symptoms to Watch For If your child exhibits any of the following persistent signs, please seek a medical evaluation: A painless lump or swelling that doesn’t go away. Bulging of the eye or sudden vision changes. Persistent nasal blockage or unexplained nosebleeds. Difficulty urinating or blood in the urine. An unexplained limp or localized bone/muscle pain. Advanced Treatment at Healius Cancer Clinic We follow a Multimodal Treatment Approach, combining various therapies to ensure the highest cure rates while preserving the child’s quality of life. A. Chemotherapy: The Vital Foundation: Since RMS cells can spread early (even if not visible on scans), systemic chemotherapy is essential. Goal: Shrink the tumor before surgery and eliminate microscopic cells after surgery. Delivery: Administered in cycles with planned rest periods to allow the body to recover. B. Precision Surgery: Our surgical goal is the complete removal of the tumor while preserving function and appearance. In many cases, we use chemotherapy first to shrink the tumor, making surgery safer and less invasive. C. Modern Radiation Therapy For tumors that cannot be entirely removed or those at high risk of returning, we use highly focused radiation. Our protocols are designed to protect growing organs and minimize long-term side effects. D. Risk-Based Customization No two children are the same. We categorize treatment into Low, Intermediate, or High-risk groups based on the tumor’s size, location, and molecular features to ensure we provide exactly the amount of treatment needed. H2: Holistic Support & Nutrition At Healius Cancer Clinic, we treat the child, not just the disease. Supportive Care: We prioritize infection prevention, pain management, and psychological support for both the child and the family. Nutrition: Our pediatric dietitians recommend high-protein diets (eggs, pulses, dairy) and frequent small meals to maintain strength during therapy. The Road to Recovery The long-term outlook for localized RMS has improved significantly with modern medicine. We provide continuous Survivorship Care to monitor growth, development, and organ function long after treatment ends. Healius Cancer Clinic – Bangalore Expert Care. Compassionate Healing. If you have concerns or need a second opinion regarding a soft tissue swelling or a diagnosis of RMS, our specialists are here to help. Location: Bangalore, India. 👉 Contact us today for a consultation. Website link: https://healiuscancerhematology.com/ Book an Appointment